Snyderman Nancy Lynn MD
CIK 0001675198
Director
Filings
16
Latest May 22, 2026
Issuers covered
3
Showing
16 of 16
Page 1
Track record
1 of 1 open-market trades scored (100% price coverage). Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).
| Horizon | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|
| 30 days | 1 | 100% | +23.9% | +23.9% | +23.9% | +23.9% |
| 90 days | 1 | 100% | +28.3% | +28.3% | +28.3% | +28.3% |
| 180 days | 1 | 100% | +2.1% | +2.1% | +2.1% | +2.1% |
| 365 days | 1 | 100% | +17.4% | +17.4% | +17.4% | +17.4% |
Issuers
Companies where Snyderman Nancy Lynn MD has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| ALKS | Alkermes Plc. | 9 | May 22, 2026 |
| LYRA | Lyra Therapeutics, Inc. | 4 | May 16, 2025 |
| AXNX | Axonics, Inc. | 3 | Nov 15, 2024 |
All filings
16 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|